PubMed · 15030704
Interferon-beta 1a and SARS coronavirus replication.
Abstract
A global outbreak of severe acute respiratory syndrome (SARS) caused by a novel coronavirus began in March 2003. The rapid emergence of SARS and the substantial illness and death it caused have made it a critical public health issue. Because no effective treatments are available, an intensive effort is under way to identify and test promising antiviral drugs. Here, we report that recombinant human interferon-beta 1a potently inhibits SARS coronavirus replication in vitro.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Lisa E Hensley, Lisa E Fritz, Peter B Jahrling, Christopher L Karp, John W Huggins, Thomas W Geisbert. 2004. Interferon-beta 1a and SARS coronavirus replication.. https://doi.org/10.3201/eid1002.030482. https://pubmed.health/record/pubmed%3A15030704/interferon-beta-1a-and-sars-coronavirus-replication
Citations retain the original authors and DOI and include this site’s record URL. If this discovery service contributed to your research, you can also cite PubMed Health by Indiciae: BibTeX · RIS.